Cargando…
Identification of cerebrospinal fluid biomarker candidates for anti-N-methyl-D-aspartate receptor encephalitis: High-throughput proteomic investigation
BACKGROUND: Although the diagnosis is mainly dependent on the detection of anti-N-methyl-D-aspartate receptor (NMDAR) antibodies in cerebrospinal fluid (CSF) and/or serum, there was no direct correlations between anti-NMDAR antibody titers in CSF and disease severity and prognosis in anti-NMDAR ence...
Autores principales: | Li, Yuchen, Yang, Keyu, Zhang, Fang, Wang, Jing, Shen, Huijun, Liu, Miaomiao, Guo, Junhong, Wang, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643472/ https://www.ncbi.nlm.nih.gov/pubmed/36389787 http://dx.doi.org/10.3389/fimmu.2022.971659 |
Ejemplares similares
-
High Level of Soluble CD146 In Cerebrospinal Fluid Might be a Biomarker of Severity of Anti-N-Methyl-D-Aspartate Receptor Encephalitis
por: Li, Qing, et al.
Publicado: (2021) -
Clinical Relevance of Cerebrospinal Fluid Antibody Titers in Anti-N-Methyl-d-Aspartate Receptor Encephalitis
por: Cai, Meng-Ting, et al.
Publicado: (2021) -
Cerebrospinal fluid light and heavy neurofilament level increased in anti‐N‐methyl‐d‐aspartate receptor encephalitis
por: Li, Jiayu, et al.
Publicado: (2019) -
Elevated Serum and Cerebrospinal Fluid CD138 in Patients With Anti-N-Methyl-d-Aspartate Receptor Encephalitis
por: Zhu, Jiajia, et al.
Publicado: (2019) -
Proteomics Study on the Cerebrospinal Fluid of Patients
with Encephalitis
por: Xiong, Liu-Lin, et al.
Publicado: (2021)